Chembio Diagnostics Reports Fourth Quarter and Full Year 2018 Financial Results

20:09 EST 7 Mar 2019 | Biotech 365

Issues 2019 Revenue Guidance MEDFORD, N.Y., March 07, 2019 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today reported financial results for the fourth quarter and year ended December 31, 2018. … Continue reading

More From BioPortfolio on "Chembio Diagnostics Reports Fourth Quarter and Full Year 2018 Financial Results"